Literature DB >> 21342661

Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems.

Olivia M Merkel1, Mengyao Zheng, Meredith A Mintzer, Giovanni M Pavan, Damiano Librizzi, Marek Maly, Helmut Höffken, Andrea Danani, Eric E Simanek, Thomas Kissel.   

Abstract

This study aimed to identify suitable siRNA delivery systems based on flexible generation 2-4 triazine dendrimers by correlating physico-chemical and biological in vitro and in vivo propn>erties of the compn>lexes with thermodynamic parameters calculated using molecular modeling. The siRNA binding propn>erties of the dendrimers and PEI 25 kDa were simulated, binding and stability were measured in SYBR Gold assays, and hydrodynamic diameters, zeta potentials, and cytotoxicity were quantified. These parameters were compared with cellular uptake of the complexes and their ability to mediate RNAi. Radiolabeled complexes were administered intravenously, and pharmacokinetic profiles and biodistribution of these polyplexes were assessed both invasively and non-invasively. All flexible triazine dendrimers formed thermodynamically more stable complexes than PEI. While PEI and the generation 4 dendrimer interacted more superficially with siRNA, generation 2 and 3 virtually coalesced with siRNA, forming a tightly intertwined structure. These dendriplexes were therefore more efficiently charge-neutralized than PEI complexes, reducing agglomeration. This behavior was confirmed by results of hydrodynamic diameters (72.0 nm-153.5 nm) and zeta potentials (4.9 mV-21.8 mV in 10 mM HEPES) of the dendriplexes in comparison to PEI complexes (312.8 nm-480.0 nm and 13.7 mV-17.4 mV in 10 mM HEPES). All dendrimers, even generation 3 and 4, were less toxic than PEI. All dendriplexes were efficiently endocytosed and showed significant and specific luciferase knockdown in HeLa/Luc cells. Scintillation counting confirmed that the generation 2 triazine complexes showed more than twofold prolonged circulation times as a result of their good thermodynamic stability. Conversely, generation 3 complexes dissociated in vivo, and generation 4 complexes were captured by the reticulo-endothelial system due to their increased surface charge. Molecular modeling proves very valuable for rationalizing experimental parameters based on the dendrimers' structural properties. Non-invasive molecular imaging predicted the in vivo fate of the complexes. Therefore, both techniques effectively promote the rapid development of safe and efficient siRNA formulations that are stable in vivo.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21342661      PMCID: PMC3134114          DOI: 10.1016/j.jconrel.2011.02.016

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  39 in total

1.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

2.  Sticky overhangs enhance siRNA-mediated gene silencing.

Authors:  Anne-Laure Bolcato-Bellemin; Marie-Elise Bonnet; Gaëlle Creusat; Patrick Erbacher; Jean-Paul Behr
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-03       Impact factor: 11.205

3.  Mechanistic studies on aggregation of polyethylenimine-DNA complexes and its prevention.

Authors:  Vikas K Sharma; Mini Thomas; Alexander M Klibanov
Journal:  Biotechnol Bioeng       Date:  2005-06-05       Impact factor: 4.530

4.  Modeling the multivalent recognition between dendritic molecules and DNA: understanding how ligand "sacrifice" and screening can enhance binding.

Authors:  Giovanni M Pavan; Andrea Danani; Sabrina Pricl; David K Smith
Journal:  J Am Chem Soc       Date:  2009-07-22       Impact factor: 15.419

5.  Computational insights into the interactions between DNA and siRNA with "rigid" and "flexible" triazine dendrimers.

Authors:  Giovanni M Pavan; Meredith A Mintzer; Eric E Simanek; Olivia M Merkel; Thomas Kissel; Andrea Danani
Journal:  Biomacromolecules       Date:  2010-03-08       Impact factor: 6.988

6.  Ethylendiamine core PAMAM dendrimers/siRNA complexes as in vitro silencing agents.

Authors:  A P Perez; E L Romero; M J Morilla
Journal:  Int J Pharm       Date:  2009-07-03       Impact factor: 5.875

7.  PAMAM dendrimers mediate siRNA delivery to target Hsp27 and produce potent antiproliferative effects on prostate cancer cells.

Authors:  Xiao-Xuan Liu; Palma Rocchi; Fan-Qi Qu; Shu-Quan Zheng; Zi-Cai Liang; Martin Gleave; Juan Iovanna; Ling Peng
Journal:  ChemMedChem       Date:  2009-08       Impact factor: 3.466

8.  Breaking up the correlation between efficacy and toxicity for nonviral gene delivery.

Authors:  Miriam Breunig; Uta Lungwitz; Renate Liebl; Achim Goepferich
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-28       Impact factor: 11.205

Review 9.  Dendrimers as versatile platform in drug delivery applications.

Authors:  Sonke Svenson
Journal:  Eur J Pharm Biopharm       Date:  2008-10-17       Impact factor: 5.571

10.  Internally cationic polyamidoamine PAMAM-OH dendrimers for siRNA delivery: effect of the degree of quaternization and cancer targeting.

Authors:  Mahesh L Patil; Min Zhang; Oleh Taratula; Olga B Garbuzenko; Huixin He; Tamara Minko
Journal:  Biomacromolecules       Date:  2009-02-09       Impact factor: 6.988

View more
  10 in total

1.  Antitumor activity and molecular dynamics simulations of paclitaxel-laden triazine dendrimers.

Authors:  Jongdoo Lim; Su-Tang Lo; Sonia Hill; Giovanni M Pavan; Xiankai Sun; Eric E Simanek
Journal:  Mol Pharm       Date:  2012-02-03       Impact factor: 4.939

Review 2.  siRNA delivery to the lung: what's new?

Authors:  Olivia M Merkel; Israel Rubinstein; Thomas Kissel
Journal:  Adv Drug Deliv Rev       Date:  2014-06-05       Impact factor: 15.470

3.  Systematic coarse-grained modeling of complexation between small interfering RNA and polycations.

Authors:  Zonghui Wei; Erik Luijten
Journal:  J Chem Phys       Date:  2015-12-28       Impact factor: 3.488

4.  Targeting the blind spot of polycationic nanocarrier-based siRNA delivery.

Authors:  Mengyao Zheng; Giovanni M Pavan; Manuel Neeb; Andreas K Schaper; Andrea Danani; Gerhard Klebe; Olivia M Merkel; Thomas Kissel
Journal:  ACS Nano       Date:  2012-10-09       Impact factor: 15.881

5.  Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Authors:  Subrata Patra; Brittany Kozura; Adela Y-T Huang; Alan E Enciso; Xiankai Sun; Jer-Tsong Hsieh; Chai-Lin Kao; Hui-Ting Chen; Eric E Simanek
Journal:  Org Lett       Date:  2013-07-19       Impact factor: 6.005

6.  Can pulmonary RNA delivery improve our pandemic preparedness?

Authors:  Olivia M Merkel
Journal:  J Control Release       Date:  2022-03-28       Impact factor: 11.467

7.  Construction and Biological Evaluation of a Novel Integrin ανβ₃-Specific Carrier for Targeted siRNA Delivery In Vitro.

Authors:  Xueqi Chen; Meng Liu; Rongfu Wang; Ping Yan; Chunli Zhang; Chao Ma; Lei Yin
Journal:  Molecules       Date:  2017-02-04       Impact factor: 4.411

Review 8.  Radiolabeled Dendrimers for Nuclear Medicine Applications.

Authors:  Lingzhou Zhao; Meilin Zhu; Yujie Li; Yan Xing; Jinhua Zhao
Journal:  Molecules       Date:  2017-08-25       Impact factor: 4.411

9.  Influence of oligospermines architecture on their suitability for siRNA delivery.

Authors:  Maha Elsayed; Vincent Corrand; Vidula Kolhatkar; Yuran Xie; Na Hyung Kim; Rohit Kolhatkar; Olivia M Merkel
Journal:  Biomacromolecules       Date:  2014-03-04       Impact factor: 6.988

Review 10.  Dendrimers as carriers for siRNA delivery and gene silencing: a review.

Authors:  Jiangyu Wu; Weizhe Huang; Ziying He
Journal:  ScientificWorldJournal       Date:  2013-10-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.